PIK3CA mutations significantly enhance the growth of Shh medulloblastoma

Medulloblastoma (MB) is the most frequent malignant brain tumour in children with a poor outcome. Divided into four molecular subgroups, MB of the Sonic hedgehog (SHH) subgroup accounts for approximately 25% of the cases and is driven by mutations within components of the SHH pathway, such as its receptors PTCH1 or SMO. A fraction of these cases additionally harbour PIK3CA mutations, the relevance of which is so far unknown. To unravel the role of Pik3ca mutations alone or in combination with a constitutively activated SHH signalling pathway, transgenic mice were used. These mice show mutated variants within Smo, Ptch1, and Pik3ca genes in cerebellar granule neuron precursors, which represent the cellular origin of SHH MB. Our results show that Pik3ca mutations alone are insufficient to cause developmental alterations or to initiate MB. However, they significantly accelerate the growth of Shh MB, induce tumour spread throughout the cerebrospinal fluid, and result in lower survival rates of mice with a double Pik3caH1047R/SmoM2 or Pik3caH1047R/Ptch1 mutation. Therefore, PIK3CA mutations in SHH MB may represent a remarkable therapeutic target for first and second line combination treatments.

[1]  Rand Arafeh,et al.  PIK3CA in cancer: The past 30 years. , 2019, Seminars in cancer biology.

[2]  L. Platanias,et al.  Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma , 2019, Scientific Reports.

[3]  Nada Jabado,et al.  Childhood Cerebellar Tumors Mirror Conserved Fetal Transcriptional Programs , 2018, Nature.

[4]  A. Iafrate,et al.  PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma , 2019, Acta neuropathologica communications.

[5]  W. Phillips,et al.  Mouse Models for Exploring the Biological Consequences and Clinical Significance of PIK3CA Mutations , 2019, Biomolecules.

[6]  M. Kool,et al.  TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma , 2019, Acta Neuropathologica.

[7]  A. Giobbie-Hurder,et al.  The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA-Mutant Breast Cancer Brain Metastases , 2019, Clinical Cancer Research.

[8]  P. Northcott,et al.  Medulloblastoma , 2019, Nature Reviews Disease Primers.

[9]  B. Győrffy,et al.  Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer , 2019, Front. Pharmacol..

[10]  Mayassa J. Bou-Dargham,et al.  Decoding Somatic Driver Gene Mutations and Affected Signaling Pathways in Human Medulloblastoma Subgroups , 2018, Journal of Cancer.

[11]  Ralitsa R. Madsen,et al.  Cancer-Associated PIK3CA Mutations in Overgrowth Disorders , 2018, Trends in molecular medicine.

[12]  A. Matheu,et al.  Targeting mTOR as a Therapeutic Approach in Medulloblastoma , 2018, International journal of molecular sciences.

[13]  D. Capper,et al.  Concurrent IDH1 and SMARCB1 Mutations in Pediatric Medulloblastoma: A Case Report , 2018, Front. Neurol..

[14]  S. Khatua,et al.  Rethinking medulloblastoma from a targeted therapeutics perspective , 2018, Journal of Neuro-Oncology.

[15]  J. Sharp,et al.  Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy , 2018, Oncotarget.

[16]  O. Delattre,et al.  Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression , 2017, Oncotarget.

[17]  Roland Eils,et al.  The whole-genome landscape of medulloblastoma subtypes , 2017, Nature.

[18]  P. Zhao,et al.  BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma , 2017, PloS one.

[19]  R. Grundy,et al.  The therapeutic potential of targeting the PI3K pathway in pediatric brain tumors , 2016, Oncotarget.

[20]  B. Wainwright,et al.  MicroRNA Biogenesis and Hedgehog-Patched Signaling Cooperate to Regulate an Important Developmental Transition in Granule Cell Development , 2016, Genetics.

[21]  G. Mills,et al.  Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy , 2015, eLife.

[22]  G. Basso,et al.  Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells , 2015, BioMed research international.

[23]  Michael C. Rusch,et al.  Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  U. Schüller,et al.  Localization of SHH medulloblastoma in mice depends on the age at its initiation , 2015, Acta Neuropathologica.

[25]  M. Kieran.  Targeted treatment for sonic hedgehog-dependent medulloblastoma. , 2014, Neuro-oncology.

[26]  A. Carnero,et al.  The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models , 2014, Front. Oncol..

[27]  Roland Eils,et al.  Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. , 2014, Cancer cell.

[28]  Haiquan Chen,et al.  PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup , 2014, PloS one.

[29]  S. Gururangan,et al.  Molecular variants and mutations in medulloblastoma , 2014, Pharmacogenomics and personalized medicine.

[30]  Elaine R. Mardis,et al.  Novel mutations target distinct subgroups of medulloblastoma , 2012, Nature.

[31]  Scott L. Pomeroy,et al.  Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas , 2012, Acta Neuropathologica.

[32]  S. Scherer,et al.  Clonal Selection Drives Genetic Divergence of Metastatic Medulloblastoma , 2012, Nature.

[33]  S. Egan,et al.  Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation. , 2011, Cancer research.

[34]  D. Sgroi,et al.  A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial Carcinomas , 2011, Clinical Cancer Research.

[35]  Jing Yuan,et al.  Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma , 2010, Science Translational Medicine.

[36]  Li Zhao,et al.  Hot-spot mutations in p110α of phosphatidylinositol 3-kinase (PI3K): Differential interactions with the regulatory subunit p85 and with RAS , 2010, Cell cycle.

[37]  Jeremy Stinson,et al.  Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. , 2009, The New England journal of medicine.

[38]  O. Delattre,et al.  Targeting the PI3K p110α Isoform Inhibits Medulloblastoma Proliferation, Chemoresistance, and Migration , 2008, Clinical Cancer Research.

[39]  Tao Sun,et al.  Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. , 2008, Cancer cell.

[40]  Scott Hamilton,et al.  In Vivo 3D Digital Atlas Database of the Adult C57BL/6J Mouse Brain by Magnetic Resonance Microscopy , 2008, Frontiers in neuroanatomy.

[41]  Bert Vogelstein,et al.  The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations , 2007, Science.

[42]  Keith L Ligon,et al.  A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. , 2006, Cancer research.

[43]  Li Zhao,et al.  Oncogenic PI3K deregulates transcription and translation , 2005, Nature Reviews Cancer.

[44]  Gord Fishell,et al.  Math1 Is Expressed in Temporally Discrete Pools of Cerebellar Rhombic-Lip Neural Progenitors , 2005, Neuron.

[45]  Alan C. Evans,et al.  A three-dimensional MRI atlas of the mouse brain with estimates of the average and variability. , 2005, Cerebral cortex.

[46]  R. McLendon,et al.  Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and Medulloblastomas , 2004, Cancer Research.

[47]  J. Ptak,et al.  High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.

[48]  Robert J. Wechsler-Reya,et al.  Transcriptional profiling of the Sonic hedgehog response: A critical role for N-myc in proliferation of neuronal precursors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. Scott,et al.  Altered neural cell fates and medulloblastoma in mouse patched mutants. , 1997, Science.